From Our Partners
Monday, June 27, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

Military Issues RFI for ‘Virus Like Particle’ Vaccine Production

by Global Biodefense Staff
May 29, 2012

The Chemical Biological Medical Systems Joint Vaccine Acquisition Program (CBMS-JVAP) is the organization responsible for developing, producing and stockpiling FDA-licensed vaccine systems to protect the military personnel from biological agents. The current CBMS-JVAP portfolio includes vaccines at varying stages of clinical development in addition to FDA licensed vaccines. 

CBMS-JVAP yesterday issued a Request for Information (RFI) seeking input from manufacturers with the capability to deliver a Good Manufacturing Practices (GMP) product that will be suitable for use in humans by the government to support non-clinical and Phase 1 studies under an Investigational New Drug (IND) application. Specifically, the government is seeking a manufacturer with the capability to conduct manufacturing of government owned Virus Like Particles (VLPs) vaccines. The government plans to initiate manufacturing efforts in early 2013.

Companies with the experience and the capability to develop, manufacture and produce a VLP vaccine under cGMP manufacturing conditions are invited to respond to the RFI.

Further details are available under Solicitation Number: W911QY-12-S-0018. The response deadline is June 13, 2012.

From Our Partners
Tags: JPEO-CBRNDRFIVaccines

Related Posts

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
Medical Countermeasures

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine
Medical Countermeasures

Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine

May 30, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC